| Literature DB >> 26023914 |
Sjaan Gomersall1, Carol Maher2, Coralie English3, Alex Rowlands2, Tim Olds2.
Abstract
UNLABELLED: The aim of this study was to investigate how previously inactive adults who had participated in a structured, partly supervised 6-week exercise program restructured their time budgets when the program ended. Using a randomised controlled trial design, 129 previously inactive adults were recruited and randomly allocated to one of three groups: a Moderate or Extensive six-week physical activity intervention (150 and 300 additional minutes of exercise per week, respectively) or a Control group. Additional physical activity was accumulated through both group and individual exercise sessions with a wide range of activities. Use of time and time spent in energy expenditure zones was measured using a computerised 24-h self-report recall instrument, the Multimedia Activity Recall for Children and Adults, and accelerometry at baseline, mid- and end-program and at 3- and 6-months follow up. At final follow up, all significant changes in time use domains had returned to within 20 minutes of baseline levels (Physical Activity 1-2 min/d, Active Transport 3-9 min/d, Self-Care 0-2 min/d, Television/Videogames 13-18 min/d in the Moderate and Extensive group, relative to Controls, respectively, p > 0.05). Similarly, all significant changes in time spent in the moderate energy expenditure zone had returned to within 1-3 min/d baseline levels (p > 0.05), however time spent in vigorous physical activity according to accelerometry estimates remained elevated, although the changes were small in magnitude (1 min/d in the Moderate and Extensive groups, relative to Controls, p = 0.01). The results of this study demonstrate strong recidivist patterns in physical activity, but also in other aspects of time use. In designing and determining the effectiveness of exercise interventions, future studies would benefit from considering the whole profile of time use, rather than focusing on individual activities, TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12610000248066.Entities:
Mesh:
Year: 2015 PMID: 26023914 PMCID: PMC4449013 DOI: 10.1371/journal.pone.0126665
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1CONSORT flow diagram of participant recruitment, enrolment and progression through the study.
Note: 3m = 3-month, 6m = 6-month.
Baseline sociodemographic and anthropometric characteristics of the sample.
| Control | Moderate | Extensive | |
|---|---|---|---|
|
| 34 | 37 | 36 |
|
| 43 (10) | 41 (12) | 45 (10) |
|
| 26.1 (5.8) | 25.4 (4.9) | 26.8 (3.9) |
|
| 104 (52) | 106 (32) | 97 (42) |
|
| 59 | 64 | 67 |
a Pre-tax income in thousands of Australian dollars per annum. One Australian dollar is approximately equivalent to one US dollar. The mean household income in Australia is about $70,000 p.a.
Mean (SD) time (min/d) spent in each superdomain by each of the groups at each time point, and P-values for main effects of Group and Time, and Group x Time interactions.
| Super-domain | Period | Control | Moderate | Extensive | P | P | P |
|---|---|---|---|---|---|---|---|
| Group | Time | Group x Time | |||||
|
|
| 6 (17) | 10 (20) | 10 (22) |
|
| 0.06 |
|
| 5 (14)a | 15 (14)a | 44 (25)a |
| |||
|
| 2 (5)ab | 27 (32)a | 52 (42)b |
| |||
|
| 3 (7)ab | 18 (29)a | 16 (28)b |
| |||
|
| 7 (13) | 13 (20) | 12 (25) | 0.49 | |||
|
|
| 203 (131) | 188 (113) | 181 (105) | 0.97 |
| 0.76 |
|
| 153 (93) | 146 (118) | 166 (129) | 0.82 | |||
|
| 123 (88) | 145 (109) | 140 (95) | 0.93 | |||
|
| 173 (107) | 182 (135) | 178 (152) | 0.95 | |||
|
| 159 (114) | 183 (118) | 172 (121) | 0.68 | |||
|
|
| 52 (28) | 57 (30) | 59 (45) |
| 0.13 | 0.65 |
|
| 49 (32)a | 63 (36) | 70 (37)a |
| |||
|
| 39 (27)ab | 67 (32)a | 69 (30)b |
| |||
|
| 51 (29)a | 56 (28) | 72 (49)a | 0.08 | |||
|
| 50 (28) | 58 (36) | 48 (27) | 0.32 | |||
|
|
| 93 (36)a | 72 (34)a | 85 (44) | 0.20 | 0.85 | 0.08 |
|
| 85 (33) | 81 (42) | 83 (36) | 0.82 | |||
|
| 88 (43) | 86 (40) | 88 (43) | 0.99 | |||
|
| 100 (55) | 80 (42) | 83 (43) | 0.17 | |||
|
| 92 (34) | 79 (51) | 86 (44) | 0.18 | |||
|
|
| 72 (50)a | 65 (49) | 45 (35)a | 0.30 | 0.07 | 0.06 |
|
| 59 (50) | 47 (41) | 48 (38) | 0.26 | |||
|
| 63 (70) | 62 (51) | 48 (53) | 0.42 | |||
|
| 54 (55) | 55 (54) | 47 (34) | 0.78 | |||
|
| 67 (48) | 57 (49) | 56 (47) | 0.47 | |||
|
|
| 124 (24) | 115 (38) | 119 (28) | 0.38 | 0.38 | 0.47 |
|
| 122 (31) | 122 (41) | 126 (30) | 0.86 | |||
|
| 121 (33) | 117 (31)a | 135 (37)a |
| |||
|
| 122 (26) | 125 (38) | 131 (36) | 0.56 | |||
|
| 127 (24) | 118 (37) | 124 (31) | 0.57 | |||
|
|
| 106 (77) | 119 (79) | 113 (72) | 0.52 | 0.06 | 0.71 |
|
| 100 (64) | 116 (81) | 108 (73) | 0.86 | |||
|
| 96 (75) | 110 (62) | 99 (61) | 0.48 | |||
|
| 92 (63) | 103 (90) | 94 (68) | 0.77 | |||
|
| 103 (75) | 120 (75) | 114 (76) | 0.72 | |||
|
|
| 72 (77) | 69 (79) | 78 (78) | 0.99 | 0.19 | 0.86 |
|
| 113 (103) | 95 (97) | 92 (101) | 0.77 | |||
|
| 103 (104) | 95 (106) | 89 (78) | 0.77 | |||
|
| 79 (97) | 109 (119) | 78 (95) | 0.24 | |||
|
| 99 (102) | 80 (88) | 76 (68) | 0.84 | |||
|
|
| 133 (65) | 118 (76) | 138 (96) | 0.18 | 0.83 | 0.47 |
|
| 149 (72)a | 124 (51) | 111 (86)a |
| |||
|
| 155 (75) | 118 (65) | 131 (89) | 0.18 | |||
|
| 144 (69) | 116 (63) | 128 (97) | 0.32 | |||
|
| 150 (84) | 119 (65) | 131 (83) | 0.44 | |||
|
|
| 467 (36)a | 505 (84)a | 483 (66) | 0.19 | 0.10 | 0.09 |
|
| 493 (52) | 526 (72)a | 492 (59)a | 0.08 | |||
|
| 508 (51) | 514 (85) | 492 (63) | 0.44 | |||
|
| 501 (71) | 500 (76) | 492 (77) | 0.85 | |||
|
| 474 (55)a | 508 (61)a | 506 (125) | 0.09 | |||
|
|
| 112 (59) | 122 (70) | 129 (88) | 0.59 | 0.23 | 0.97 |
|
| 112 (70) | 104 (61) | 101 (74) | 0.77 | |||
|
| 144 (90)ab | 98 (52)a | 98 (80)b |
| |||
|
| 120 (64) | 97 (61) | 120 (78) | 0.33 | |||
|
| 112 (78) | 105 (58) | 116 (78) | 0.88 |
Note: Summary data are raw scores and significant differences are indicated in bold. N = 107 (Control group, n = 34, Moderate group, n = 37, Extensive group, n = 36). Values with the same superscript were significantly different on post-hoc analysis. TV = television.
Changes in time (min/d) spent in the 11 superdomains in the Moderate and Extensive groups relative to the Control group at mid-program, end-program, and 3 and 6 months follow-up.
| Change in use of time superdomains relative to Control: | ||||||||
|---|---|---|---|---|---|---|---|---|
| Superdomain | Moderate | Extensive | ||||||
|
|
|
|
|
|
|
|
| |
|
|
|
|
| +2 |
|
|
| +1 |
|
| +8 | +37 | +24 | +39 | +35 | +39 | +27 | +35 |
|
| +9 |
| 0 | +3 |
|
| +14 | –9 |
|
| +17 | +19 | +1 | +8 | +6 | +8 | –9 | +2 |
|
| –5 | +6 | +8 | –3 | +16 | +12 | +20 | +16 |
|
| +9 |
| +12 | 0 | +9 |
| +14 | +2 |
|
| +3 | +1 | –2 | +4 | +1 | –4 | –5 | +4 |
|
| –15 | –5 | +33 | –16 | –27 | –20 | –7 | –29 |
|
| –10 | –22 | –13 | –16 |
| –29 | –21 | –24 |
|
| –5 | –32 | –39 | –4 | –17 | –32 | –25 | +6 |
|
| –19 |
| –34 | –18 | –28 |
| –17 | –13 |
Note: 3M = 3 months, 6M = 6 months. Significant differences according to Table 2 are shown in bold.
Fig 2Changes in time from baseline to 6-month follow in the Moderate (top panel) and Extensive (bottom panel) groups, relative to Controls.
Note: AT = Active Transport, PA = Physical Activity, TV/VG = Television/Videogames.
Mean (SD) time (min/d) spent in each energy expenditure zone by each of the groups at each time point according to MARCA and accelerometry, and P-values for main effects of Group and Time, and Group x Time interactions.
| EE Zone | Period | Control | Moderate | Extensive | P | P | P |
|---|---|---|---|---|---|---|---|
| Group | Time | Group x Time | |||||
|
| |||||||
|
|
| 467 (36) | 505 (84) | 483 (66) | 0.61 | 0.09 | 0.46 |
|
| 493 (52) | 526 (72) | 492 (59) | 0.35 | |||
|
| 508 (51) | 514 (85) | 492 (63) | 0.24 | |||
|
| 501 (71) | 500 (76) | 492 (77) | 0.74 | |||
|
| 474 (55) | 508 (61) | 506 (125) | 0.28 | |||
|
|
| 662 (75) | 655 (85) | 641 (108) | 0.37 |
| 0.56 |
|
| 634 (96) | 584 (98) | 598 (120) | 0.34 | |||
|
| 630 (112)a | 598 (109) | 568 (109)a | 0.08 | |||
|
| 627 (106) | 621 (92) | 607 (131) | 0.71 | |||
|
| 638 (104) | 630 (85) | 626 (120) | 0.93 | |||
|
|
| 200 (74) | 172 (60) | 196 (68) | 0.48 | 0.29 | 0.36 |
|
| 201 (64) | 202 (64) | 203 (80) | 0.98 | |||
|
| 204 (70) | 185 (61)a | 222 (82)a | 0.13 | |||
|
| 203 (77) | 198 (64) | 193 (72) | 0.86 | |||
|
| 211 (77)a | 173 (67)a | 196 (65) | 0.10 | |||
|
|
| 108 (47) | 99 (44) | 114 (65) | 0.50 | 0.59 | 0.47 |
|
| 104 (53) | 118 (77) | 109 (39) | 0.97 | |||
|
| 88 (45)ab | 121 (60)a | 117 (53)b |
| |||
|
| 102 (49) | 106 (70)a | 131 (84)a | 0.09 | |||
|
| 108 (55) | 109 (56) | 100 (53) | 0.78 | |||
|
|
| 3 (8)a | 9 (19)a | 6 (11) |
|
|
|
|
| 8 (14)a | 11 (12)b | 38 (25)ab |
| |||
|
| 11 (29)a | 21 (36) | 41 (21)a |
| |||
|
| 7 (20)a | 16 (33) | 16 (26)a |
| |||
|
| 8 (13) | 20 (51) | 12 (18) | 0.37 | |||
|
| |||||||
|
|
| 1,155 (76) | 1,183 (64) | 1,162 (70) | 0.19 |
| 0.22 |
|
| 1,168 (61)a | 1,154 (67)b | 1,120 (74)ab |
| |||
|
| 1,163 (58)a | 1,148 (60) | 1,122 (63)a |
| |||
|
| 1,178 (62) | 1,181 (65) | 1,147 (72) | 0.12 | |||
|
| 1,181 (54) | 1,189 (65) | 1,182 (80) | 0.87 | |||
|
|
| 250 (68) | 223 (58) | 243 (68) | 0.40 |
| 0.17 |
|
| 234 (57) | 233 (58) | 250 (67) | 0.46 | |||
|
| 245 (53) | 235 (52) | 259 (57) | 0.30 | |||
|
| 230 (58) | 222 (54) | 248 (70) | 0.27 | |||
|
| 225 (49) | 212 (58) | 221 (75) | 0.68 | |||
|
|
| 34 (16) | 33 (13) | 35 (10) |
|
| 0.92 |
|
| 34 (15)a | 44 (15)a | 59 (15)a |
| |||
|
| 32 (14)ab | 51 (16)a | 56 (23)b |
| |||
|
| 32 (13)a | 35 (17) | 41 (16)a | 0.08 | |||
|
| 33 (18) | 35 (15) | 35 (16) | 0.84 | |||
|
|
| 0.8 (2.1) | 0.8 (1.9) | 0.7 (1.7) |
|
| 0.84 |
|
| 0.7 (1.0)ab | 4.0 (5.4)a | 5.1 (6.6)b |
| |||
|
| 0.5 (0.9)ab | 3.9 (5.4)a | 3.3 (4.9)b |
| |||
|
| 0.4 (0.7)ab | 1.5 (2.1)a | 1.9 (3.0)b |
| |||
|
| 0.7 (2.5)ab | 2.0 (4.7)a | 1.5 (4.0)b |
| |||
Note: Summary data are raw scores and significant differences are indicated in bold. MARCA; N = 107 (Control group, n = 34, Moderate group, n = 37, Extensive group, n = 36). Accelerometry; N = 95 (Control group, n = 28, Moderate group, n = 35, Extensive group, n = 32). Average number of monitored days for included accelerometry data are baseline −6.9±0.5 days, mid −6.8± 0.8 days, end −6.6±1.5 days, 3 month −6.6±1.4 days, 6 month −6.7±1.1 days. Values with the same superscript were significantly different on post-hoc analysis. EE = energy expenditure, METs = metabolic equivalents, VLPA = very light physical activity, LPA = light physical activity, MPA = moderate physical activity, VPA = vigorous physical activity.
Changes in time (min/d) spent in energy expenditure zones in the Moderate and Extensive groups relative to the Control group at mid-program, end-program and 3- and 6-month follow up according to the MARCA and accelerometry.
| Change in times spent in EE zones relative to Control: | ||||||||
|---|---|---|---|---|---|---|---|---|
| EE Zone | Moderate | Extensive | ||||||
|
|
|
|
|
|
|
|
| |
|
| ||||||||
|
| –5 | –32 | –39 | –4 | –17 | –32 | –25 | +16 |
|
| –43 | –25 | +1 | -1 | –15 | –41 | +1 | +9 |
|
| +29 | +9 | +23 | –10 | +6 | +22 | –6 | –11 |
|
| +23 |
| +13 | +10 | -1 |
| +23 | –14 |
|
|
| +4 | +3 | +6 |
|
|
| +1 |
|
| ||||||||
|
|
| -43 | -25 | -20 |
|
| -38 | -6 |
|
| +26 | +17 | +19 | +14 | +23 | +21 | +25 | +3 |
|
|
|
| +4 | +3 |
|
| +8 | +1 |
|
|
|
|
|
|
|
|
|
|
Note: 3M = 3 months, 6M = 6 months. Significant differences according to Table 4 are shown in bold. EE = energy expenditure, METs = metabolic equivalents, VLPA = very light physical activity, LPA = light physical activity, MPA = moderate physical activity, VPA = vigorous physical activity.
Fig 3Changes in time (min/d) relative to Controls, from baseline to 6 months follow-up in time spent by the Moderate (left panel) and Extensive (right panel) groups in the different energy expenditure zones according to MARCA recalls (panel A) and accelerometry (Panel B).
Note: SED/SLEEP = sedentary/sleep, VLPA = very light physical activity, LPA = light physical activity, MPA = moderate physical activity, VPA = vigorous physical activity.